.

ALKERMES reported $-15066000 in EBITDA for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acadia Pharmaceuticals ACAD:US $ -33.14M 79.36M
Acorda Therapeutics ACOR:US $ -6.2M 1.23M
Amgen AMGN:US $ 3004M 337M
Biogen BIIB:US $ 1075.7M 401M
Biomarin Pharmaceutical BMRN:US $ 64.42M 7.75M
Bluebird Bio BLUE:US $ -99.42M 19.92M
Bristol Myers Squibb BMY:US $ 5780M 8M
Eli Lilly And LLY:US $ 1999.4M 1006.2M
Gilead Sciences GILD:US $ 2585M 837M
Horizon Pharma HZNP:US $ 244.43M 47.12M
Intra Cellular Therapies ITCI:US $ -87.75M 15.26M
IONIS PHARMACEUT IONS:US $ -81.13M 27.92M
JAZZ PHA JAZZ:US $ 282.55M 15.29M
Johnson & Johnson JNJ:US $ 8036M 1273M
Marinus Pharmaceuticals MRNS:US $ -36.67M 20.05M
Minerva Neurosciences NERV:US $ -6.96M 1.02M
Nektar Therapeutics NKTR:US $ -44.27M 67.08M
Neurocrine Biosciences NBIX:US $ 58.6M 52.2M
Otsuka Holdings 4578:JP Y 69662M 5302M
Pfizer PFE:US $ 12921M 1739M
Regeneron Pharmaceuticals REGN:US $ 1381.3M 20.4M
Revance Therapeutics RVNC:US $ -52.39M 4.45M
Teva Pharmaceutical Industries TEVA:US $ 1092M 20M
Vertex Pharmaceuticals VRTX:US $ 1156.6M 87.3M